Cell Mol Immunol Nat Publishing Group
Current clinical evidence suggests GLP-1 receptor agonists like semaglutide have limited passage into breast milk, yet many lactating women remain uncertain about whether these medications are truly safe for their nursing infants
In 2026, the global market for GLP-1 Meal Replacement Market is estimated at USD 2.4 billion
FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes
This bill aims to increase the transparency of prescription drug prices for Minnesota's Medical Assistance and MinnesotaCare programs by establishing a state PBM and requiring it to report all negotiated prices, rebates, and discounts to the state commissioner
PA requests for non-preferred cytokine and CAM antagonist drugs used to treat NMOSD may be submitted on the Portal, by fax, or by mail (but not using the STAT-PA system.) Kineret is a non-preferred drug used to treat NOMID